Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active disease as compared to imaging with CT alone. As reported in the September issue of the Journal of Nuclear Medicine, detailed PET/CT scans resulted in a change in treatment plans for nearly 50% of patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup